800 N. Glebe Road , Suite 500 , Arlington , Virginia 22203 (Address of principal executive offices) (Zip Code) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ...

Evolent Health, Inc. (NYSE:EVH) Q4 2020 Earnings Conference Call February 25, 2021 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Jack Rogoff - Goldman Sachs Cal Sternick - Cowen Matt Shea - Piper Sandler David Larsen - BTIG Operator Welcome to Evolent Health’s Earnings Conference Call for the Quarter and Year Ended December 31, 2020. As a reminder, this conference call is being recorded ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-K _________________________ (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock of Evolent Health, Inc., par value $0.01 per shareEVH New York Stock Exchange (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPO ...

Evolent Health, Inc. (NYSE:EVH) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Robert Jones - Goldman Sachs Matthew Gilmore - Baird Jessica Tassan - Piper Sandler Charles Rhyee - Cowen Sandy Draper - Truist Operator Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended September 30, 2020. As a reminder, this conferen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 | --- | --- | --- | --- | --- | --- | --- | --- | |-------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ Evolent Health, Inc. | --- | --- | --- | --- ...

Evolent Health, Inc. (NYSE:EVH) Q2 2020 Earnings Conference Call August 4, 2020 5:00 PM ET Company Participants Frank Williams - Co-Founder & CEO John Johnson - CFO Seth Blackley - Co-Founder, President Conference Call Participants Ryan Daniels - William Blair Jack Rogoff - Goldman Sachs Matthew Gilmore - Baird Charles Rhyee - Cowen Richard Close - Canaccord Genuity Sandy Draper - SunTrust Anne Samuel - JPMorgan Operator Welcome to Evolent Health Earnings Conference Call for the Quarter Ended June 30, 2020. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ Evolent Health, Inc. | --- | --- | --- | -- ...

| --- | --- | |----------------------------------------------------------------------|-------| | | | | | | | Bank of America Health Care Conference: Evolent Health May 13, 2020 | | | | | | | | Safe Harbor Statement Certain statements in this presentation and in other written or oral statements made by us or on our behalf are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). A forward-looking statement is a statement that is not a historical fa ...

Evolent Health, Inc. (NYSE:EVH) Q1 2020 Results Earnings Conference Call May 7, 2020 5:00 PM ET Company Participants Frank Williams - Co-Founder, Chief Executive Officer John Johnson - Chief Financial Officer Seth Blackley - Co-Founder, President Conference Call Participants Charles Rhyee - Cowen Robert Jones - Goldman Sachs Ryan Daniels - William Blair Sandy Draper - SunTrust Jessica Tassan - Piper Sandler Operator Welcome to Evolent Health earnings conference call for the quarter ended March 31, 2020. As ...